|
DE1670684A1
(de)
|
1966-04-01 |
1970-12-03 |
Hoechst Ag |
Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
|
|
WO1990012321A1
(en)
|
1989-03-31 |
1990-10-18 |
The Cancer Institute Board |
Halogenated dna ligand radiosensitisers for cancer therapy
|
|
US5667975A
(en)
|
1994-05-06 |
1997-09-16 |
The University Of North Carolina |
Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans
|
|
WO1996006831A1
(en)
|
1994-08-26 |
1996-03-07 |
Auckland Division Cancer Society Of New Zealand Inc. |
Novel dna-targeted alkylating agents
|
|
US5643935A
(en)
|
1995-06-07 |
1997-07-01 |
The University Of North Carolina At Chapel Hill |
Method of combatting infectious diseases using dicationic bis-benzimidazoles
|
|
US5668166A
(en)
|
1995-06-07 |
1997-09-16 |
Georgia State University Research Foundation, Inc. |
Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor
|
|
AUPN449295A0
(en)
|
1995-07-28 |
1995-08-24 |
Inner And Eastern Health Care Network, The |
Radioprotectors
|
|
US5770617A
(en)
|
1996-03-20 |
1998-06-23 |
Rutgers, The State University Of New Jersey |
Terbenzimidazoles useful as antifungal agents
|
|
US6087493A
(en)
|
1997-02-05 |
2000-07-11 |
Regents Of The University Of Texas System |
Porphyrin compounds as telomerase inhibitors
|
|
US5935982A
(en)
|
1997-02-28 |
1999-08-10 |
The University Of North Carolina At Chapel Hill |
Methods of treating retroviral infection and compounds useful therefor
|
|
US6063801A
(en)
|
1998-02-12 |
2000-05-16 |
Rutgers, The State University Of New Jersey |
Heterocyclic topoisomerase poisons
|
|
TWI244481B
(en)
|
1998-12-23 |
2005-12-01 |
Pfizer |
3-azabicyclo[3.1.0]hexane derivatives useful in therapy
|
|
JP4507026B2
(ja)
|
1999-04-06 |
2010-07-21 |
東洋紡績株式会社 |
ハレーション防止用組成物およびそれを用いた感光性樹脂積層体
|
|
IL146125A0
(en)
|
1999-04-30 |
2002-07-25 |
Slil Biomedical Corp |
Novel quinones as disease therapies
|
|
PT1230223E
(pt)
|
1999-11-05 |
2004-07-30 |
Aventis Pharma Sa |
Derivados de oligobenzimidazoles e a sua utilizacao como agentes de transfeccao de adn
|
|
US6613787B2
(en)
|
1999-12-20 |
2003-09-02 |
The University Of North Carolina At Chapel Hill |
Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
GB0011092D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (III)
|
|
US20030199521A1
(en)
|
2001-01-13 |
2003-10-23 |
Dykstra Christine C. |
Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
|
|
US6709929B2
(en)
|
2001-06-25 |
2004-03-23 |
North Carolina State University |
Methods of forming nano-scale electronic and optoelectronic devices using non-photolithographically defined nano-channel templates
|
|
BR0212078A
(pt)
|
2001-08-31 |
2004-09-28 |
Neurochem Int Ltd |
Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto
|
|
WO2003045929A1
(fr)
*
|
2001-11-26 |
2003-06-05 |
Takeda Chemical Industries, Ltd. |
Derive bicyclique, procede de production de ce derive et utilisation correspondante
|
|
WO2003048140A1
(fr)
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Compose azole et utilisation medicinale de celui-ci
|
|
JP2004024114A
(ja)
|
2002-06-26 |
2004-01-29 |
Shigeori Takenaka |
電気化学的二本鎖ｄｎａ検出試薬としての新規インターカレータ
|
|
RU2352568C9
(ru)
|
2002-08-09 |
2009-06-27 |
Астразенека Аб |
[1,2,4]оксадиазолы (варианты), способ их получения, фармацевтическая композиция и способ ингибирования активации метаботропных глютаматных рецепторов-5
|
|
EP2573079A3
(en)
|
2002-08-23 |
2015-03-11 |
Novartis AG |
Benzimidazole quinolinones and uses thereof
|
|
US20050256157A1
(en)
|
2002-08-23 |
2005-11-17 |
Chiron Corporation |
Combination therapy with CHK1 inhibitors
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
ZA200600424B
(en)
|
2003-08-01 |
2007-05-30 |
Genelabs Tech Inc |
Bicyclic imidazol derivatives against flaviviridae
|
|
AU2003265967A1
(en)
|
2003-09-05 |
2005-04-21 |
Georgia State University Research Foundation, Inc |
Novel amidine compounds for treating microbial infections
|
|
CA2544186A1
(en)
|
2003-11-07 |
2005-05-26 |
Chiron Corporation |
Inhibition of fgfr3 and treatment of multiple myeloma with benzimidazole quinolinones
|
|
EP1719765A4
(en)
|
2004-02-19 |
2009-01-07 |
Banyu Pharma Co Ltd |
NEW SULFONAMIDE DERIVATIVE
|
|
CA2599304C
(en)
|
2004-02-27 |
2014-07-08 |
Peter Maccallum Cancer Institute |
Cell targeting conjugates
|
|
WO2005086754A2
(en)
|
2004-03-08 |
2005-09-22 |
Georgia State University Research Foundation, Inc. |
Dicationic compounds for activity against trichomonas vaginalis
|
|
JP2008512346A
(ja)
|
2004-09-09 |
2008-04-24 |
アステラス製薬株式会社 |
Ｖａｐ−１阻害活性を有するチアゾール誘導体
|
|
US8710038B2
(en)
|
2004-09-17 |
2014-04-29 |
Exelixis, Inc. |
Pyrazole kinase modulators and methods of use
|
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
|
WO2008041966A2
(en)
|
2005-08-12 |
2008-04-10 |
United States Government As Represented By The Secretary Of The United States Army And The U.S. Army Medical Research & Materiel Command |
Broad spectrum antibacterial compounds
|
|
CA2620269A1
(en)
|
2005-08-29 |
2007-03-08 |
Vertex Pharmaceuticals Incorporated |
3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
|
|
EP1954287B2
(en)
|
2005-10-31 |
2016-02-24 |
Merck Sharp & Dohme Corp. |
Cetp inhibitors
|
|
CA2673417C
(en)
|
2006-12-21 |
2015-09-15 |
Roger Francis Martin |
Radioprotective benzimidazole compounds and related methods
|
|
CA2681813A1
(en)
|
2007-03-27 |
2009-01-08 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
|
GB0707934D0
(en)
|
2007-04-24 |
2007-05-30 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7662526B2
(en)
|
2007-05-04 |
2010-02-16 |
Xerox Corporation |
Photoconductors
|
|
US8198307B2
(en)
|
2007-05-11 |
2012-06-12 |
Korea Research Institute Of Chemical Technology |
Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
|
|
JP2009005594A
(ja)
|
2007-06-26 |
2009-01-15 |
Kyoto Univ |
遺伝子診断機能性蛍光色素の製造方法
|
|
US20110015158A1
(en)
|
2007-12-11 |
2011-01-20 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
EP2240491B1
(en)
|
2008-01-09 |
2015-07-15 |
Amura Therapeutics Limited |
TETRAHYDROFURO(2,3-b)PYRROL-3-ONE DERIVATIVES AS INHIBITORS OF CYSTEINE PROTEINASES
|
|
AR072008A1
(es)
|
2008-06-13 |
2010-07-28 |
Merck & Co Inc |
Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
|
|
JP5762971B2
(ja)
|
2008-12-03 |
2015-08-12 |
プレシディオ ファーマシューティカルズ インコーポレイテッド |
Ｈｃｖｎｓ５ａの阻害剤
|
|
KR20110098779A
(ko)
|
2008-12-03 |
2011-09-01 |
프레시디오 파마슈티칼스, 인코포레이티드 |
Ｈｃｖ ｎｓ5ａ의 억제제
|
|
JP2012513409A
(ja)
|
2008-12-23 |
2012-06-14 |
アボット・ラボラトリーズ |
抗ウイルス化合物
|
|
CA2753313A1
(en)
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
KR101219487B1
(ko)
|
2009-03-03 |
2013-01-15 |
덕산하이메탈(주) |
비스벤조이미다졸 화합물 및 이를 이용한 유기전기소자, 그단말
|
|
EP2430016B1
(en)
|
2009-05-13 |
2020-04-01 |
University Of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
|
DK2455376T3
(en)
|
2009-06-11 |
2015-03-02 |
Abbvie Bahamas Ltd |
Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011007756A1
(ja)
|
2009-07-13 |
2011-01-20 |
武田薬品工業株式会社 |
複素環化合物及びその用途
|
|
US9072761B2
(en)
|
2009-08-14 |
2015-07-07 |
Clemson University Research Foundation (Curf) |
Methods and compositions related to viral inhibition
|
|
WO2011031904A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
CN102791687B
(zh)
|
2009-12-18 |
2015-02-11 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011099832A2
(en)
|
2010-02-12 |
2011-08-18 |
Crystalgenomics, Inc. |
Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
|
|
TW201139438A
(en)
|
2010-03-24 |
2011-11-16 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
|
TW201200522A
(en)
|
2010-03-24 |
2012-01-01 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
|
CA2794145A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
WO2011151618A2
(en)
|
2010-06-01 |
2011-12-08 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile-associated disease
|
|
NZ608685A
(en)
|
2010-09-28 |
2014-10-31 |
Dae Woong Pharma |
Novel method of preparing benzoimidazole derivatives
|
|
WO2012044567A2
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Imidazole derivatives
|
|
CA2819894A1
(en)
|
2010-12-16 |
2012-06-21 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
|
EP2694060A4
(en)
|
2011-04-01 |
2014-09-10 |
Univ Utah Res Found |
SUBSTITUTED 3- (1H-BENZO [D] IMIDAZOL-2-YL) -1H-INDAZOLE ANALOGUES AS INHIBITORS OF PDK1 KINASE
|
|
US8785436B2
(en)
|
2011-05-16 |
2014-07-22 |
Hoffmann-La Roche Inc. |
1,3-oxazines as BACE 1 and/or BACE2 inhibitors
|
|
CA2837207A1
(en)
|
2011-06-01 |
2012-12-06 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
|
CA2841102C
(en)
|
2011-07-15 |
2019-08-13 |
Janssen Pharmaceuticals, Inc. |
Novel substituted indole derivatives as gamma secretase modulators
|
|
WO2013036749A1
(en)
|
2011-09-07 |
2013-03-14 |
University Of Kansas |
Hcv helicase inhibitors and methods of use thereof
|
|
WO2013049567A1
(en)
|
2011-09-29 |
2013-04-04 |
The Broad Institute, Inc. |
Compounds for the treatment of mycobacterial infections
|
|
WO2013055607A1
(en)
|
2011-10-13 |
2013-04-18 |
Merck Sharp & Dohme Corp. |
Mineralocorticoid receptor antagonists
|
|
EP2768517A4
(en)
|
2011-10-17 |
2015-03-11 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
WO2013074387A1
(en)
|
2011-11-14 |
2013-05-23 |
Merck Sharp & Dohme Corp. |
Imidazole derivatives
|
|
PT2794597T
(pt)
|
2011-12-21 |
2018-01-16 |
Ono Pharmaceutical Co |
Derivados de piridinona e pirimidinona como inibidores do fator xia
|
|
MX352181B
(es)
|
2012-02-02 |
2017-11-13 |
Idorsia Pharmaceuticals Ltd |
Compuestos 4- (benzoimidazol-2-il) -tiazol y derivados aza relacionados.
|
|
EP2647628A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Substituted tricyclic compounds with activity towards ep1 receptors
|
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
|
TW201412709A
(zh)
|
2012-09-28 |
2014-04-01 |
Sunshine Lake Pharma Co Ltd |
作為丙型肝炎抑制劑的螺環化合物及其在藥物中的應用
|
|
US9047780B2
(en)
|
2012-11-16 |
2015-06-02 |
Robert Bosch Gmbh |
Collision mitigation systems and methods using driver attentiveness
|
|
CA2892159A1
(en)
|
2012-11-21 |
2014-05-30 |
Pooi Nguon LIM |
Information medium and a method of producing the same
|
|
CN103848819B
(zh)
|
2012-11-29 |
2017-04-12 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的螺环化合物、药物组合物及它们在药物中的应用
|
|
CN103880823B
(zh)
|
2012-12-21 |
2017-12-05 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的螺环化合物及其在药物中的应用
|
|
CN104981164A
(zh)
|
2013-02-13 |
2015-10-14 |
住友化学株式会社 |
害虫防治组合物和其用途
|
|
EP2961408A1
(en)
|
2013-02-28 |
2016-01-06 |
Signal Pharmaceuticals, LLC |
Treatment of cancer with tor kinase inhibitors
|
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
|
US9334291B2
(en)
|
2013-06-06 |
2016-05-10 |
AB Pharma Ltd. |
Antiviral compounds highly effective as HCV-NS5A inhibitor
|
|
WO2015002754A2
(en)
*
|
2013-06-21 |
2015-01-08 |
Zenith Epigenetics Corp. |
Novel bicyclic bromodomain inhibitors
|
|
US9586944B2
(en)
|
2013-07-15 |
2017-03-07 |
The Scripps Research Institute |
Specific targeting of RNA expanded repeat sequences
|
|
US20150051208A1
(en)
|
2013-08-14 |
2015-02-19 |
Boehringer Ingelheim International Gmbh |
Pyridinones
|
|
ES2712090T3
(es)
|
2013-08-29 |
2019-05-09 |
Scripps Research Inst |
Moléculas pequeñas ensambladas modularmente para el tratamiento de la distrofia miotónica tipo 1
|
|
US9920014B2
(en)
|
2013-09-19 |
2018-03-20 |
The Florida International University Board Of Trustees |
Selective inhibition of bacterial topoisomerase I
|
|
JP2016534044A
(ja)
|
2013-10-11 |
2016-11-04 |
ジェネンテック， インコーポレイテッド |
癌の免疫療法のためのｃｂｐ／ｅｐ３００ブロモドメインインヒビターの使用
|
|
JP6217317B2
(ja)
|
2013-10-30 |
2017-10-25 |
株式会社リコー |
色素増感太陽電池
|
|
CN104610272B
(zh)
|
2013-11-05 |
2017-03-29 |
上海唐润医药科技有限公司 |
环状黄酮或异黄酮类化合物及其用途
|
|
CN103728294B
(zh)
|
2013-12-17 |
2016-05-11 |
中国科学院化学研究所 |
二苯并咪唑联咔唑类化合物在用于特异性结合核酸g-四链体结构及在抗肿瘤药物中的应用
|
|
WO2015110048A1
(en)
|
2014-01-23 |
2015-07-30 |
Sunshine Lake Pharma Co., Ltd. |
Bridged ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
|
|
CN103952009B
(zh)
|
2014-05-08 |
2015-12-30 |
中国工程物理研究院化工材料研究所 |
一种近红外宽光谱金属配合物染料及其制备方法
|
|
PL408251A1
(pl)
|
2014-05-19 |
2015-11-23 |
Celon Pharma Spółka Z Ograniczoną Odpowiedzialnością |
Skondensowane pochodne triazolu jako inhibitory fosfodiesterazy 10A
|
|
CN104030988B
(zh)
|
2014-06-25 |
2016-07-06 |
上海道亦化工科技有限公司 |
一种基于苯并咪唑的电子传输化合物
|
|
CN104193738B
(zh)
|
2014-08-21 |
2016-05-18 |
上海道亦化工科技有限公司 |
一种基于苯并咪唑的电子传输化合物
|
|
WO2016044694A1
(en)
|
2014-09-19 |
2016-03-24 |
Genentech, Inc. |
Use of cbp/ep300 and bet inhibitors for treatment of cancer
|
|
WO2016097863A1
(en)
|
2014-12-17 |
2016-06-23 |
Zenith Epigenetics Corp. |
Inhibitors of bromodomains
|
|
WO2016097870A1
(en)
|
2014-12-17 |
2016-06-23 |
Zenith Epigenetics Corp. |
Substituted bicyclic compounds as bromodomain inhibitors
|
|
CN104710410B
(zh)
|
2015-01-23 |
2017-10-10 |
固安鼎材科技有限公司 |
一种联苯并咪唑衍生物、其制备方法及其应用
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|